AQR Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

AQR Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,739	Closed	-$207K	–	2242
2019 Q1	$207K	Sell	7,739 -1,428	-16%	-$36.3K	﹤0.01%	2068
2018 Q4	$207K	Buy	+9,167	New	+$358K	﹤0.01%	2067
2018 Q1	–	Sell	-2,886	Closed	-$364K	–	2303
2017 Q4	$364K	Sell	2,886 -5,277	-65%	-$676K	﹤0.01%	2012
2017 Q3	$1.12M	Buy	8,163 +7,075	+650%	+$946K	﹤0.01%	1630
2017 Q2	$155K	Buy	+1,088	New	+$168K	﹤0.01%	2153
2016 Q4	–	Sell	-517	Closed	-$40K	–	2307
2016 Q3	$40K	Sell	517 -1,220	-70%	-$97.7K	﹤0.01%	2238
2016 Q2	$149K	Sell	1,737 -527	-23%	-$48.3K	﹤0.01%	2136
2016 Q1	$210K	Buy	+2,264	New	+$226K	﹤0.01%	2103
2015 Q4	–	Sell	-6,127	Closed	-$914K	–	2337
2015 Q3	$914K	Sell	6,127 -296	-5%	-$217K	﹤0.01%	1477
2015 Q2	$6.09M	Buy	6,423 +1,633	+34%	+$1.34M	0.01%	761
2015 Q1	$3.51M	Buy	4,790 +3,315	+225%	+$2.49M	0.01%	904
2014 Q4	$1.17M	Buy	1,475 +745	+102%	+$401K	﹤0.01%	1573
2014 Q3	$291K	Hold	730	–	–	﹤0.01%	2203
2014 Q2	$197K	Buy	+730	New	+$157K	﹤0.01%	2377

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AQR Capital Management's TTPH Position: Q2 2019 in Review

AQR Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 7,739 shares — an estimated $207K sold.

AQR Capital Management first reported a position in TTPH in Q2 2014 and held it in 14 quarters. The position peaked at $6.09M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

AQR Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
AQR Capital Management sold 7,739 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $207K.
AQR Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2014 and held it in 14 quarters.
AQR Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $6.09M in Q2 2015.
66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on AQR Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.